IDH2 and astrocytoma (excluding glioblastoma): We observed MGMT promoter methylation in IDH-mutant astrocytomas of CNS WHO grade 2 less frequently than in CNS WHO grade 3 or 4 tumors, a finding which might contribute to the lack of prognostic association of the MGMT status.